UCHL1 appears in the proteostasis network under direct ATG8-homolog processing
and under the broader UPS UCH deubiquitinase class. The workbook row was used as
triage context; the LC3/autophagy source was resolved to PMID:29462615 and
cached before being used as evidence.
Falcon deep research: just deep-research-falcon human UCHL1 timed out after
600s with Provider falcon timed out after 600s; no Falcon findings were
available to incorporate into this review.
UCHL1 encodes ubiquitin carboxyl-terminal hydrolase isozyme L1, a cysteine-type
deubiquitinase / ubiquitin C-terminal hydrolase. UniProt summarizes the core
reaction as thiol-dependent hydrolysis of bonds formed by the C-terminal glycine
of ubiquitin and notes that UCHL1 maintains a monoubiquitin pool important for
UPS and autophagy-lysosome pathways [UniProt:P09936 "recognizes and hydrolyzes
a peptide bond at the C-terminal glycine of ubiquitin"; UniProt:P09936 "to
maintain a stable pool of monoubiquitin"].
Classic enzymology supports this core function. UCH proteins are described as
deubiquitinating enzymes that hydrolyze C-terminal esters and amides of ubiquitin
PMID:9521656. The same study
concludes that UCH enzymes preferentially cleave small leaving groups from
ubiquitin and generate free monomeric ubiquitin from ubiquitin proproteins
PMID:9521656.
Active-site work on UCH-L1 identified catalytic C90 and H161, supporting the
cysteine protease mechanism PMID:8639624. Variant,
mechanistic, and structure papers further support hydrolase activity and ubiquitin
binding [PMID:12705903 "examined their structure (using circular dichroism) and
hydrolase activities"; PMID:16475834 "UCHs cleave Ub-X bonds"; PMID:20439756
"Mutation of the distal-site, surface-exposed phenylalanine to alanine reduces
ubiquitin binding and severely impairs the catalytic activity of the enzyme";
PMID:23359680 "near complete loss of UCHL1 hydrolase activity"].
UCHL1 has a direct autophagy-related context through LC3. The 2018 BBRC paper
reports that UCHL1 overexpression inhibits LC3 puncta/autophagosome formation,
that this depends on DUB activity, and that UCHL1 affects autophagy by interacting
with LC3 [PMID:29462615 "UCHL1 overexpression inhibits LC3 puncta formation and
is dependent on its DUB activity"; PMID:29462615 "UCHL1 may affect autophagy by
interacting with LC3"]. This supports regulation of macroautophagy as a real but
context-specific non-core process and supports a possible future ATG8-family
protein deubiquitination term.
Another cached autophagy paper shows that UCHL1 deficiency worsens hIAPP-induced
autophagy/lysosomal defects in beta cells PMID:24879150. This
supports keeping autophagy/lysosome pathway effects as non-core proteostasis
context rather than treating UCHL1 as a core autophagy machinery component.
Protein catabolism and proteasome-mediated catabolism annotations should be
interpreted through the more specific protein deubiquitination and monoubiquitin
maintenance functions. Broad protein catabolic process annotations are too vague
for the direct UCH enzymology.
UCHL1 interacts with alpha-2A adrenergic receptor and inhibits agonist-mediated
p44/42 MAPK activation [PMID:19477270 "Uch-L1 binds preferentially to the
alpha(2A)AR subtype"; PMID:19477270 "alpha(2)AR agonist mediated activation of
p44/42 MAP Kinase was drastically decreased in the presence of Uch-L1"]. These
specific receptor binding / signaling inhibitor annotations are supported but
non-core.
UCHL1 also has cancer/metabolism and Parkinson disease model contexts, including
HIF-1alpha deubiquitination and glycolysis-linked PD phenotypes [PMID:25615526
"UCHL1 promotes metastases as a deubiquitinating enzyme for HIF-1α"; PMID:34244144
"loss of UCHL1 destabilizes pyruvate kinase (PKM)"]. These are direct substrate
or pathway contexts but not the conserved core function.
The many protein binding rows should not be retained as core molecular
functions. The evidence points to specific interactions such as COPS5/JAB1,
Parkin, alpha-2A adrenergic receptor, EGFR-network proteins, and large
neurodegeneration interactomes, but generic protein binding does not describe
UCHL1's biochemical role.